Show simple item record

dc.contributor.advisorMerav Socolovsky
dc.contributor.authorHwang, Yung
dc.date2022-08-11T08:08:38.000
dc.date.accessioned2022-08-23T16:02:13Z
dc.date.available2022-08-23T16:02:13Z
dc.date.issued2019-12-18
dc.date.submitted2020-01-10
dc.identifier.doi10.13028/4yrg-sh06
dc.identifier.urihttp://hdl.handle.net/20.500.14038/31280
dc.description.abstractThe cell division cycles of differentiating cells are coordinated so as to generate sufficient numbers of mature cells. The cell cycle may also regulate the process of differentiation, in ways that are not well understood. We previously discovered that during erythropoiesis, the cell cycle is synchronized with a specific developmental switch, where erythroid progenitors known as colony-forming-unit-erythroid (CFU-e) transition from a self-renewal state to a state of erythroid terminal differentiation (ETD). This switch takes place during a single cell cycle S phase and is dependent on S-phase progression. My work shows that this S phase is unusual, in that it is shorter than S phase in preceding cycles, as a result of a global increase in replication fork speed. I found that the CDK inhibitor, p57KIP2, negatively regulates replication fork speed in self-renewing CFU-e, and its down-regulation at the switch to ETD results in S-phase shortening. p57KIP2-mediated inhibition of CDK2 is essential for CFU-e self-renewal. It exerts this effect by reducing replication stress and also reducing the probability of transition from CFU-e to ETD, promoting CFU-e self-renewal instead. CDK2 inhibiting drugs that mimic the action of p57KIP2 stimulate erythropoiesis both in vitro and in vivo, through expansion of the CFU-e pool. In addition to p57KIP2, E2f4 also regulates S-phase shortening and the efficiency of the CFU-e to ETD transition. Overall, my work shows that S-phase speed regulates a key erythroid cell fate decision, and suggests a possible translational application of CDK2 inhibiting drugs in the stimulation of erythropoiesis.
dc.language.isoen_US
dc.publisherUniversity of Massachusetts Medical Schoolen_US
dc.rightsCopyright is held by the author, with all rights reserved.
dc.subjectErythropoiesis
dc.subjectcell fate decision
dc.subjectcell cycle
dc.subjectS-phase speed
dc.subjectreplication fork speed
dc.subjectCDK2 inhibition
dc.subjectCell Biology
dc.titleThe Role of S-phase Speed During an Erythroid Transcriptional Switch
dc.typeDoctoral Dissertation
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2067&context=gsbs_diss&unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_diss/1058
dc.legacy.embargo2022-01-10T00:00:00-08:00
dc.identifier.contextkey16170560
refterms.dateFOA2022-08-30T15:03:50Z
html.description.abstract<p>The cell division cycles of differentiating cells are coordinated so as to generate sufficient numbers of mature cells. The cell cycle may also regulate the process of differentiation, in ways that are not well understood. We previously discovered that during erythropoiesis, the cell cycle is synchronized with a specific developmental switch, where erythroid progenitors known as colony-forming-unit-erythroid (CFU-e) transition from a self-renewal state to a state of erythroid terminal differentiation (ETD). This switch takes place during a single cell cycle S phase and is dependent on S-phase progression. My work shows that this S phase is unusual, in that it is shorter than S phase in preceding cycles, as a result of a global increase in replication fork speed. I found that the CDK inhibitor, p57<sup>KIP2</sup>, negatively regulates replication fork speed in self-renewing CFU-e, and its down-regulation at the switch to ETD results in S-phase shortening. p57<sup>KIP2</sup>-mediated inhibition of CDK2 is essential for CFU-e self-renewal. It exerts this effect by reducing replication stress and also reducing the probability of transition from CFU-e to ETD, promoting CFU-e self-renewal instead. CDK2 inhibiting drugs that mimic the action of p57<sup>KIP2</sup> stimulate erythropoiesis both in vitro and in vivo, through expansion of the CFU-e pool. In addition to p57<sup>KIP2</sup>, E2f4 also regulates S-phase shortening and the efficiency of the CFU-e to ETD transition. Overall, my work shows that S-phase speed regulates a key erythroid cell fate decision, and suggests a possible translational application of CDK2 inhibiting drugs in the stimulation of erythropoiesis.</p>
dc.identifier.submissionpathgsbs_diss/1058
dc.contributor.departmentMolecular, Cell and Cancer Biology
dc.description.thesisprogramCancer Biology
dc.identifier.orcid0000-0003-0098-8963


Files in this item

Thumbnail
Name:
Hwang_Yung_PDFA.pdf
Size:
22.51Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record